+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2018

  • ID: 4629780
  • Clinical Trials
  • July 2018
  • Region: Global
  • 142 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Galapagos NV
  • GlaxoSmithKline Plc
  • Immunomedics Inc
  • MORE
Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2018

Summary

The Author's clinical trial report, “Sicca Syndrome (Sjogren) Global Clinical Trials Review, H2, 2018" provides an overview of Sicca Syndrome (Sjogren) clinical trials scenario. This report provides top line data relating to the clinical trials on Sicca Syndrome (Sjogren). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The Author's Clinical Trial Reports are generated using the Author’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AstraZeneca Plc
  • Bristol-Myers Squibb Co
  • F. Hoffmann-La Roche Ltd
  • Galapagos NV
  • GlaxoSmithKline Plc
  • Immunomedics Inc
  • MORE
List of Tables
List of Figures

Report Guidance

Clinical Trials Report Coverage
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Sicca Syndrome (Sjogren) Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Sicca Syndrome (Sjogren)
May 22, 2018: Wize Pharma Announces Presentation of New Data on LO2A in the Treatment of Dry Eye Syndrome in Patients with Sjogren's Syndrome
Clinical Trial Profile Snapshots

Appendix

Abbreviations
Definitions
Research Methodology
Secondary Research
About
Contact Us
Disclaimer
Source

List of Tables
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region, 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2018*
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2
Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*

List of Figures
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Region (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, North America, Top Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2018*
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, G7 Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018*
Proportion of Sicca Syndrome (Sjogren) to Immunology Clinical Trials, E7 Countries (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Phase (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics, Global, Clinical Trials by Trial Status, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, by End Point Status, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2
Sicca Syndrome (Sjogren) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Key Sponsors, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018*
Sicca Syndrome (Sjogren) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018*
Methodology 141
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Bristol-Myers Squibb Co
  • GlaxoSmithKline Plc
  • Galapagos NV
  • UCB SA
  • Pamplona Capital Management LLP
  • Kadmon Corp LLC
  • Immunomedics Inc
  • AstraZeneca Plc
Note: Product cover images may vary from those shown
Adroll
adroll